Edition:
United States

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

61.46USD
1:24pm EST
Change (% chg)

$0.04 (+0.07%)
Prev Close
$61.42
Open
$61.58
Day's High
$61.58
Day's Low
$60.93
Volume
324,335
Avg. Vol
1,220,585
52-wk High
$77.50
52-wk Low
$55.80

Latest Key Developments (Source: Significant Developments)

Express Scripts appoints James Havel as CFO
Tuesday, 24 Oct 2017 04:07pm EDT 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts Holding Co appoints James M. Havel chief financial officer.Express Scripts Holding Co - ‍Eric Slusser, executive vice president and chief financial officer, is leaving company​.  Full Article

Express Scripts reports Q3 GAAP earnings per share $1.46
Tuesday, 24 Oct 2017 04:01pm EDT 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts announces 2017 third quarter results.Q3 adjusted earnings per share $1.90.Q3 GAAP earnings per share $1.46.Q3 earnings per share view $1.90 -- Thomson Reuters I/B/E/S.Sees Q4 2017 adjusted earnings per share $2.03 to $2.11.Express Scripts holding co qtrly ‍adjusted claims of 343.6 million, down 1 pct​.Qtrly ‍revenues $24,683 million versus $25,410 million.Express Scripts holding-‍increasing expected 2018 retention rate for 2017 selling season, excluding impact of remaining coventry business to be above 95 percent​.Says ‍company expects to formalize plan for its enterprise value initiative by end of 2017​.Express Scripts holding-‍enterprise value initiative estimated to cost about $600 million to $650 million ,to deliver cumulative savings of nearly $1.2 billion by 2021​.Express Scripts holding-‍increased its guidance for fy 2017 adjusted earnings per diluted share from a range of $6.95 to $7.05 to a range of $6.97 to $7.05​.Says ‍adjusted earnings per diluted share for q4 of 2017 is estimated to be in range of $2.03 to $2.11​.Express Scripts holding co says ‍expects total adjusted claims for q4 of 2017 to be in range of 347 million to 363 million​.Q4 earnings per share view $2.05 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $6.99 -- Thomson Reuters I/B/E/S.  Full Article

Express scripts to acquire Evicore Healthcare for $3.6 bln
Tuesday, 10 Oct 2017 09:00am EDT 

Oct 10 (Reuters) - Express Scripts Holding Co :Express Scripts to acquire Evicore Healthcare; accelerates company's shift to patient benefit management.Express Scripts Holding Co - deal for ‍$3.6 billion​.Express Scripts Holding Co - ‍expects acquisition to be accretive to adjusted diluted earnings per share in its first full year of operation​.Express Scripts Holding - ‍acquiring Evicore from current investors including General Atlantic, TA Associates, and Ridgemont Equity Partners​.Express Scripts Holding Co says ‍Evicore will operate as a standalone business unit within Express Scripts​.  Full Article

Express Scripts wins dismissal of lawsuit over its dealings with Anthem; plaintiffs can amend complaint
Wednesday, 2 Aug 2017 09:58am EDT 

Aug 2 (Reuters) - Express scripts wins dismissal of shareholder lawsuit over its disclosures about its relationship with anthem antm.n -- u.s. Court ruling issued on aug 1:.  Full Article

Express Scripts says a new contract with Anthem would be "significantly less favorable" to co
Tuesday, 25 Jul 2017 04:49pm EDT 

July 25 (Reuters) - Anthem Inc ::Express Scripts-based on recent statements made,other actions taken by Anthem, co believes unlikely its contract with anthem will be extended‍​.Express Scripts says " if we do enter into new contract with anthem, it would be on terms significantly less favorable to us than current contract".Express Scripts - Anthem contract generated about 19 pct of total consolidated revenues for both three and six months ended june 30, 2017, respectively.  Full Article

Express Scripts Q2 earnings per share $1.37
Tuesday, 25 Jul 2017 04:01pm EDT 

July 25 (Reuters) - Express Scripts Holding Co :Express Scripts announces 2017 second quarter results.Q2 adjusted earnings per share $1.73.Q2 GAAP earnings per share $1.37.Q2 earnings per share view $1.71 -- Thomson Reuters I/B/E/S.Sees Q3 2017 adjusted earnings per share $1.88 to $1.92.Express Scripts Holding Co - increased its guidance for 2017 adjusted earnings per diluted share from a range of $6.90 to $7.04 to a range of $6.95 to $7.05.Express Scripts Holding Co - expects total adjusted claims for Q3 of 2017 to be in range of 340 million to 350 million.Express Scripts Holding Co - adjusted earnings per diluted share for Q3 of 2017 is estimated to be in range of $1.88 to $1.92.Express Scripts Holding Co - qtrly revenues $25,347.5‍​ million versus $25,222.3 million.Express Scripts Holding Co - estimate initiative will deliver savings of approximately $550 million to $600 million annually by 2021.Express scripts holding co qtrly adjusted claims of 350.0 million, flat.Express Scripts Holding Co - company is updating its expected 2018 retention rate for 2017 selling season to be in range of 94% to 96%.Express Scripts Holding Co - company expects to formalize plan for our enterprise value initiative by end of 2017.Express Scripts Holding Co - company's enterprise value initiative is currently estimated to cost approximately $600 million to $650 million.Q3 earnings per share view $1.89 -- Thomson Reuters I/B/E/S.  Full Article

Jazz Pharmaceuticals says on June 28, its unit entered into pharmacy master services agreement with Express Scripts specialty distribution services
Monday, 3 Jul 2017 04:31pm EDT 

July 3 (Reuters) - Jazz Pharmaceuticals Plc ::Jazz Pharmaceuticals says on June 28, its unit entered into a pharmacy master services agreement with express scripts specialty distribution services.Says ‍under master services agreement, jazz is billed monthly for services performed by express scripts.Jazz Pharmaceuticals - pursuant to agreement express scripts provides exclusive distribution and other services to jazz related to sale and marketing of xyrem oral solution in u.s..Jazz Pharmaceuticals plc - master services agreement will expire on June 30, 2019, subject to a one-year extension at option of jazz.  Full Article

Express Scripts announces launch ofInside Rx, a new, partially owned subsidiary
Monday, 8 May 2017 08:15am EDT 

May 8 (Reuters) - Express Scripts Holding Co :Express scripts holding - announced launch of inside rx, a new, partially owned unit to expand access to brand and generic medications for patients.  Full Article

Amerisourcebergen reports new 5-year pharmaceutical supply agreement with Express Scripts
Monday, 1 May 2017 06:30am EDT 

May 1 (Reuters) - Amerisourcebergen Corp ::Amerisourcebergen announces new five-year pharmaceutical supply agreement with express scripts.Agreement extends through september 30, 2022.Amerisourcebergen Corp - fiscal year 2016 revenue contribution from that agreement was approximately $23 billion.Amerisourcebergen Corp- amerisourcebergen and express scripts' most recent supply agreement began in oct. 2012 and was set to expire in september 2017.Signed a new five-year agreement to supply pharmaceuticals to express scripts holding company.  Full Article

Express Scripts reports Q1 GAAP earnings per share $0.90
Monday, 24 Apr 2017 04:01pm EDT 

April 24 (Reuters) - Express Scripts Holding Co : :Express Scripts announces 2017 first quarter results; provides update on anthem relationship and visibility into core PBM business excluding contribution from Anthem, Coventry and Catamaran.Q1 adjusted earnings per share $1.33.Q1 GAAP earnings per share $0.90.Q1 earnings per share view $1.32 -- Thomson Reuters I/B/E/S.Sees Q2 2017 adjusted earnings per share $1.70 to $1.74.Express scripts holding co qtrly adjusted claims of 351.7 million, down 1pct.Expects total adjusted claims for Q2 of 2017 to be in range of 343 million to 353 million.Express Scripts Holding Co says qtrly revenue $24.65 billion versus. $24.79 billion last year.Increased its guidance for 2017 adjusted earnings per diluted share to a range of $6.90 to $7.04.Q1 earnings per share view $1.32, revenue view $24.99 billion -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $6.93 -- Thomson Reuters I/B/E/S.Q2 earnings per share view $1.68 -- Thomson Reuters I/B/E/S.Express Scripts Holding - recently told by anthem management that anthem intends to move its business when co's current contract with anthem expires on Dec 31, 2019.Express Scripts Holding Co - anthem is not interested in continuing discussions regarding pricing concessions for 2017-2019.Express Scripts Holding Co - Anthem has "not provided formal written notice that it does not intend to renew its contract with company".  Full Article

BRIEF-Express Scripts Holding files preliminary prospectus supplement related to potential three-part senior notes offering‍​‍​

* Express Scripts Holding Co files preliminary prospectus supplement related to a potential three-part senior notes offering - sec filing‍​‍​ Source text - http://bit.ly/2Af8DkJ Further company coverage: